STOCKS MIXED; GAMESTOP SURGES ON REDDIT BET

ISM report shows further contraction in U.S. manufacturing activity

Alligator Bioscience AB (publ) (7AL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

0.0953

+0.0023

(+2.47%)

As of 10:31AM CEST. Market open.

Loading interactive chart...

ACCESSWIRE
Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology
LUND, SE / ACCESSWIRE / June 03, 2024 / Alligator Bioscience (STO:ATORX) Publication in world-leading clinical oncology journal validates the quality and potential implications of Phase 2 OPTIMIZE-1 results The study reported Objective Response Rate ...
ACCESSWIRE
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting
OPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDAC The encouraging duration of response (median 12.5 months) and overall survival (median 14.3 months) ...